Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT: NCT04600115 · RECRUITING

NCT IDNCT04600115
StatusRECRUITING
Start Date2017-03-03
Completion2027-03-03
SponsorUniversity of Utah (OTHER)
First posted
Last updated

Brief Summary

This study's main specific aims are; 1. To develop robust acquisition and reconstruction methods specifically for the study of microvascular cardiac remodeling with MRI which will include very innovative quantitative perfusion methods, as well as fibrosis quantification, longitudinal strain, and phase contrast imaging for flow. 2. Test the new methods for identifying the clinical task of characterizing HFpEF.

Frequently Asked Questions

What is New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)?

New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF) is a clinical trial registered under NCT04600115. Current status: RECRUITING.

What is the status of NCT04600115?

The current status of NCT04600115 (New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)) is: RECRUITING.

When did New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF) start?

New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF) started on 2017-03-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.